Quantcast

All Posts Tagged Tag: ‘diabetes treatment’

Diabetes, Obesity Linked by Missing Protein

It’s been clear now for decades that obesity is somehow linked to the development of diabetes. As Americans have grown to staggering proportions, diabetes diagnoses have risen accordingly, even among teens. Exactly why this is the case isn’t fully understood, but researchers are now closing in on some answers. A new study published in the journal Cell Reports suggests that …

Read More

New Study to Examine Vitamin D, Diabetes Prevention Link

The U.S. National Institutes of Health (NIH) today announced that a new clinical trial to research vitamin D’s role in diabetes prevention has begun. The “large-scale” study, nicknamed D2d, will look at around 2,500 people over the age of 30 with prediabetes. Researchers hope to determine whether vitamin D can prevent or delay the onset of type 2 diabetes in …

Read More

Insulin Pump Sensors Reduce Hypoglycemia, Shows Study

A new study published today in The Journal of the American Medical Association (JAMA) shows that certain sensors on insulin pumps can significantly decrease hypoglycemic episodes in those with type 1 diabetes. The sensors in question detect when blood sugar falls below a certain level, then cuts off insulin delivery. The study looked at 95 type 1 diabetes patients from …

Read More

Millions of Blood Glucose Test Strips Recalled by the FDA

The U.S. Food and Drug Administration (FDA) announced today that Nova Diabetes Care has voluntarily recalled its glucose test strips. The recalled strips are marketed under the “Nova Max Blood Glucose Test Strips” and “Nova Max Plus Glucose Meter Kits” brands. The FDA estimates that the recall affects up to 62 million Nova test strips manufactured from December 2011 and …

Read More

FDA Warns Companies Selling Fake, Illegal Diabetes Treatments

The U.S. Food and Drug Administration (FDA) this week announced that it is “taking action” to remove illegal diabetes treatments from store shelves. The agency has sent letters to 15 companies, notifying them that their products illegal. “The FDA is committed to protecting consumers from the dangers of these illegally sold products,” said Howard Sklamberg, director of the Office of …

Read More

New Diabetes Treatment Uses Injectable “Smart Sponge”

Researchers from several U.S. universities this week announced a new diabetes treatment method that uses a “smart sponge” as a drug delivery device. The injectable sponge-like material surrounds an insulin core, expanding and contracting in response to blood sugar levels to regulate the amount of insulin released. The researchers also believe the technique could be used as a targeted cancer …

Read More

Diabetes Drug Works Differently Than Was Previously Thought

For half a century one of the most popular and most-prescribed classes of diabetes drugs has been biguanides, which includes the drug metformin. Metformin helps to keep liver glucose output in check, which, in turn, keeps blood sugar down in type 2 diabetes patients. Until now, however, doctors weren’t exactly sure how metformin, was accomplishing this feat. “Overall, metformin lowers …

Read More

Diabetes Treatment Shown to Improve Memory For Alzheimer’s Patients

A new study shows that a drug used to treat insulin resistance in diabetics could improve cognitive performance in some people with Alzheimer’s disease. In the study, published this week in the Journal of Neuroscience, the drug rosiglitazone was used on mice that have been genetically engineered to serve as models for Alzheimer’s disease. Researchers found that treatment with the …

Read More

Diabetes Treatment: Bristol-Myers Buys Amylin Pharmaceuticals

Amylin Pharmaceuticals, which develops a handful of diabetes treatment medications, was purchased by Bristol-Myers Squibb Co. for a staggering $5 billion in cash. The buyout comes about a month after FDA approval for generic versions of Bristol-Myers’ blood thinner Plavix was announced, indicating that the company is looking to make some changes to its trajectory. The aforementioned drug, the patents …

Read More